Tudor–Eliade Ciuleanu

机构：Institute of Oncology Prof. Dr. Ion Chiricuta, Spitalul Clinic Județean de Urgență Cluj-Napoca · ORCID：0000-0003-0958-5597

发表论文 312 篇 · 总被引 41023 次 · h-index 71

代表论文

• Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy (2025 · New England Journal of Medicine · 被引 229)
• Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer (2025 · New England Journal of Medicine · 被引 208)
• Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA (2025 · ESMO Open · 被引 32)
• Overall survival with neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) in patients with resectable NSCLC in CheckMate 816. (2025 · Journal of Clinical Oncology · 被引 11)
• Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304. (2025 · Journal of Clinical Oncology · 被引 10)
• FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC). (2025 · Journal of Clinical Oncology · 被引 7)